Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Tax Provisions (2016 - 2025)

Avanos Medical (AVNS) has disclosed Tax Provisions for 13 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 110.64% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, up 139.41% year-over-year, with the annual reading at $6.7 million for FY2025, 139.41% up from the prior year.
  • Tax Provisions hit $2.5 million in Q4 2025 for Avanos Medical, up from $200000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $38.0 million in Q3 2021 to a low of -$46.0 million in Q2 2021.
  • Historically, Tax Provisions has averaged -$555000.0 across 5 years, with a median of $1.4 million in 2022.
  • Biggest five-year swings in Tax Provisions: plummeted 1486.21% in 2021 and later soared 788.89% in 2023.
  • Year by year, Tax Provisions stood at $2.6 million in 2021, then soared by 76.92% to $4.6 million in 2022, then crashed by 145.65% to -$2.1 million in 2023, then tumbled by 1019.05% to -$23.5 million in 2024, then soared by 110.64% to $2.5 million in 2025.
  • Business Quant data shows Tax Provisions for AVNS at $2.5 million in Q4 2025, $200000.0 in Q3 2025, and $900000.0 in Q2 2025.